A significant advance in cancer investigation is occurring with the use of VHH fragments to restore mutated p53. This essential tumor inhibitor protein is frequently inactivated in several types of tumors, leading https://ledbookmark.com/story7764295/mini-antibodies-revive-tumor-suppressor-p53-new-potential-approach-for-cancer-treatment